You are here

  • Home
  • Archive
  • Volume 2, Issue 4
  • Low-molecular-weight heparin was more cost-effective than intravenous heparin for treating proximal venous thrombosis

Article metrics

Article menu
Download PDFPDF
Economics
Low-molecular-weight heparin was more cost-effective than intravenous heparin for treating proximal venous thrombosis

 

Online download statistics by month:

Online download statistics by month: November 2011 to October 2023

AbstractFullPdf
Nov 2011002
Dec 2011001
May 2012001
Aug 2012001
Oct 2012001
Jan 2013001
Mar 2013001
Apr 2013001
Jul 2013001
Jan 2014001
Feb 2014010
Mar 2014012
Apr 2014002
May 2014005
Aug 2014011
Sep 2014010
Oct 2014021
Dec 2014004
Feb 2015002
Mar 2015100
Jun 2015003
Jul 2015002
Sep 2015003
Jan 2016001
Mar 2016008
Jun 2016001
Aug 2016001
Sep 2016002
Oct 2016003
Feb 2017002
Jul 2017002
Aug 2018001
Oct 2018001
Nov 2018001
Jan 2019001
Feb 2019001
Mar 2019001
May 2019001
Jul 2019001
Aug 2019001
Dec 2019002
Jan 2020001
Feb 2020003
May 2020001
Aug 2020001
Sep 2020002
Oct 2020001
Nov 2020001
Jul 2021001
Oct 2021002
Nov 2021001
Jan 2022003
May 2022002
Jun 2022001
Sep 2022002
Dec 2022001
Jan 2023003
Feb 2023001
Apr 2023001
May 2023003
Jun 2023001
Jul 2023006
Aug 2023003
Oct 2023001
Total16109